[1] Usama SM, Zhao B, Burgess K.A near-IR fluorescent dasatinib derivative that localizes in cancer cells[J]. Bioconjug Chem, 2019, 30(4):1175-1181. [2] 赖漪娆, 丁晔伟, 施琳俊, 等. 近红外荧光成像在头颈部鳞癌手术治疗中的应用[J]. 临床口腔医学杂志, 2018, 34(8):506-509. [3] 张贺, 张彩勤, 赵勇, 等. 基于临床手术标本的胰腺癌原位移植模型建立及评价[J]. 中国实验动物学报, 2018, 26(3):296-301. [4] Liberale G, Vankerckhove S, Galdon MG, et al.Fluorescence imaging after intraoperative intravenous injection of indocyanine green for detection of lymph node metastases in colorectal cancer[J]. Eur J Surg Oncol, 2015, 41(9):1256-1260. [5] Feng L, Yang Y, Huo X, et al.Highly selective NIR probe for intestinal β-glucuronidase and high-throughput screening inhibitors to therapy intestinal damage[J]. ACS Sens, 2018, 3(9):1727-1734. [6] Yang JA, Kong WH, Sung DK, et al.Hyaluronic acid-tumor necrosis factor-related apoptosis-inducing ligand conjugate for targeted treatment of liver fibrosis[J]. Acta Biomater, 2015, 12:174-182. [7] Keereweer S, Mol IM, Kerrebijn JD, et al.Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer[J]. J Surg Oncol, 2012, 105(7):714-718. [8] Xu M, Rettig MP, Sudlow G, et al.Preclinical evaluation of Mab CC188 for ovarian cancer imaging[J]. Int J Cancer, 2012, 131(6):1351-1359. [9] Tsuchimochi M, Yamaguchi H, Hayama K, et al. Imaging of metastatic cancer cells in sentinel lymph nodes using affibody probes and possibility of a theranostic approach[J]. Int J Mol Sci, 2019,20(2): pii: E427. [10] Yi X, Yan F, Wang F, et al.IR-780 dye for near-infrared fluorescence imaging in prostate cancer[J]. Med Sci Monit, 2015, 21:511-517. [11] Shao C, Liao CP, Hu P, et al.Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer[J]. PLoS One, 2014, 9(2):e88967. [12] Yi X, Wang F, Qin W, et al.Near-infrared fluorescent probes in cancer imaging and therapy: an emerging field[J]. Int J Nanomedicine, 2014, 9:1347-1365. [13] Thomas RG, Moon MJ, Surendran SP, et al.MHI-148 cyanine dye conjugated chitosan nanomicelle with NIR light-trigger release property as cancer targeting theranostic agent[J]. Mol Imaging Biol, 2018, 20(4):533-543. [14] Yang X, Shi C, Tong R, et al.Near IR heptamethine cyanine dye-mediated cancer imaging[J]. Clin Cancer Res, 2010, 16(10):2833-2844. [15] Shi C, Wu JB, Pan D.Review on near-infrared heptamethine cyanine dyes as theranostic agents for tumor imaging, targeting, and photodynamic therapy[J]. J Biomed Opt, 2016, 21(5):50901-50911. [16] Miranda D, Huang H, Kang H, et al.Highly-soluble cyanine J-aggregates entrapped by liposomes for in vivo optical imaging around 930 nm[J]. Theranostics, 2019, 9(2):381-390. [17] Zhao N, Zhang C, Zhao Y, et al.Optical imaging of gastric cancer with near-infrared heptamethine carbocyanine fluorescence dyes[J]. Oncotarget, 2016, 7(35):57277-57289. [18] Zhang C, Zhao Y, Zhang H, et al. The application of heptamethine cyanine dye HC and indocyanine green for imaging and targeting in xenograft models of hepatocellular carcinoma[J]. Int J Mol Sci, 2017, 18(6):pii:E1332. [19] van der Vorst JR, Schaafsma BE, Verbeek FP, et al. Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients[J]. Oral Oncol, 2013, 49(1):15-19. [20] Shi C, Wu JB, Chu GC, et al.Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF1α/OATPs signaling axis[J]. Oncotarget, 2014, 5(20):10114-10126. [21] Wu JB, Shi C, Chu GC, et al.Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor[J]. Biomaterials, 2015, 67:1-10. [22] An J, Zhao N, Zhang C, et al.Heptamethine carbocyanine DZ-1 dye for near-infrared fluorescence imaging of hepatocellular carcinoma[J]. Oncotarget, 2017, 8(34):56880-56892. [23] Kim JS, Kim YH, Kim JH, et al.Development and in vivo imaging of a PET/MRI nanoprobe with enhanced NIR fluorescence by dye encapsulation[J]. Nanomedicine(Lond), 2012, 7(2):219-229. [24] Wu J, Pan D, Chung LW.Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer[J]. Transl Androl Urol, 2013, 2(3):254-264. [25] Lutje S, Rijpkema M, Goldenberg DM, et al.Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer[J]. Cancer Res, 2014, 74(21):6216-6223. [26] Zhang Y, Xiao L, Popovic K, et al.Novel cancer-targeting SPECT/NIRF dual-modality imaging probe (99m)Tc-PC-1007: synthesis and biological evaluation[J]. Bioorg Med Chem Lett, 2013, 23(23):6350-6354. [27] Wu JB, Shao C, Li X, et al.Near-infrared fluorescence imaging of cancer mediated by tumor hypoxia and HIF1alpha/OATPs signaling axis[J]. Biomaterials, 2014, 35(28):8175-8185. [28] Hirche C, Murawa D, Mohr Z, et al.ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer[J]. Breast Cancer Res Treat, 2010, 121(2): 373-378. [29] Hagenbuch B, Stieger B.The SLCO (former SLC21) superfamily of transporters[J]. Mol Aspects Med, 2013, 34(2-3):396-412. [30] Liu T, Li Q.Organic anion-transporting polypeptides: a novel approach for cancer therapy[J]. J Drug Target, 2014, 22(1):14-22. [31] Yuan J, Yi X, Yan F, et al.Nearinfrared fluorescence imaging of prostate cancer using heptamethine carbocyanine dyes[J]. Mol Med Rep, 2015, 11(2):821-828. [32] Wang Y, Liu T, Zhang E, et al.Preferential accumulation of the near infrared heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells[J]. Biomaterials, 2014, 35(13):4116-4124. |